When a GCC founder raises their first outside money, they will almost always be offered one of three structures: a SAFE, a convertible note, or a priced round. They achieve the same goal — getting capital into the company — but they do it in very different ways, with very different consequences for your cap table, your dilution, and how much control you keep. Choosing the wrong instrument, or misunderstanding the one you signed, is a mistake that surfaces months later when the terms convert. This guide explains how each instrument works, which tends to be used at which stage in the region, how caps and discounts affect your dilution, the pros and cons for founders, and how to choose the right one.

How Each Instrument Works

A SAFE — Simple Agreement for Future Equity — is a contract that gives an investor the right to receive equity in the company at a future priced round, in exchange for money today. Critically, it is not debt: there is no interest, no maturity date, and no obligation to repay. The SAFE simply sits on the cap table until a triggering event, usually your next priced round, at which point it converts into shares. Its simplicity is the point — a SAFE can often be signed quickly with minimal legal cost.

A convertible note works similarly in that it also converts into equity at a later round, but structurally it is debt. It accrues interest and carries a maturity date — a deadline by which it must either convert or be repaid. If you have not raised a qualifying priced round by maturity, the note can come due, giving the investor leverage: they may demand repayment, renegotiate, or convert on terms set at that moment.

A priced round is the traditional approach: you and the investor agree on a valuation now, and the investor buys newly issued shares at that price immediately. There is no "convert later" mechanism because the equity is issued today. Priced rounds involve more legal work — full share subscription and shareholder agreements — but everyone knows exactly what they own the moment the deal closes.

Which Is Common at Which Stage Regionally

Across early-stage fundraising, the instrument tends to track the stage. At pre-seed, convertible instruments dominate because they let founders and investors defer the hard question of valuation until there is more evidence to price on. SAFEs in particular have become the default at the earliest stage globally — recent market data shows SAFEs making up the large majority of pre-seed deals. Their speed and low cost make them well suited to small, early checks from angels and pre-seed funds.

Convertible notes remain common where investors want the downside protection that debt provides, or where local conventions and investor preference favor a note over a SAFE. In the GCC, founders will encounter both, and the choice often comes down to the specific investor's familiarity and preference rather than a hard regional rule. Some regional angels and family offices are more comfortable with notes because the debt framing is familiar.

Priced rounds become the norm as the round gets larger and the company more mature — typically at seed proper and certainly by Series A. Once a lead investor is writing a check large enough to justify negotiating a real valuation, the certainty of a priced round outweighs the speed of a convertible. A practical pattern many GCC founders follow is to raise an initial pre-seed on SAFEs or notes, then do a priced seed round once there is enough traction to support a defensible valuation.

Caps, Discounts, and Dilution Effects

Because SAFEs and convertible notes postpone valuation, they use two mechanisms to reward early investors for taking early risk: the valuation cap and the discount.

A valuation cap sets the maximum valuation at which the instrument converts into equity, regardless of how high the priced round's actual valuation turns out to be. If an investor puts in money on a SAFE with a cap, and your next round prices the company well above that cap, the investor converts as if the company were valued at the cap — giving them more shares for their money and rewarding them for backing you early. Caps for pre-seed and seed-stage instruments commonly fall in a range of roughly $6M to $15M, though the right number depends entirely on your traction and market.

A discount gives the investor a percentage reduction on the price paid by new investors in the priced round — commonly in the region of 10% to 20%. If the round prices at a certain per-share value and the SAFE carries a 20% discount, the early investor converts at 80% of that price. Many instruments include both a cap and a discount, and the investor receives whichever gives them more shares.

The dilution effect matters: because caps and discounts hand early investors more shares than their cash alone would buy at the priced round's headline valuation, they dilute founders more than the raw dollar amount suggests. A low cap in particular can convert into a much larger ownership stake than founders expect. Stacking several uncapped or low-capped instruments before a priced round can also create nasty surprises when they all convert at once, so founders should model the fully diluted cap table before signing, not after.

Pros and Cons for Founders

SAFEs are fast, cheap, and founder-friendly in the sense that they carry no interest and no maturity date — there is no clock forcing you to raise by a deadline. Their downside is that dilution is deferred and can be underestimated; because the SAFE only converts later, founders sometimes lose track of how much of the company they have already promised away, especially when several SAFEs stack up.

Convertible notes share the deferral benefit but add real risk through the maturity date and interest. If you cannot raise a qualifying round before the note matures, you may face repayment demands or a forced renegotiation from a position of weakness. The interest also increases the amount that converts into equity, adding a little extra dilution. The upside is that some investors will only invest via a note, so it can widen your pool of willing backers.

Priced rounds give certainty — everyone knows the valuation and the ownership split immediately, and there is no deferred dilution to be surprised by later. The trade-off is cost and speed: they require full legal documentation, a lead investor willing to set a price, and more negotiation. For a small early check, that overhead is often not worth it; for a substantial round, the clarity is worth every dirham.

Choosing the Right Instrument

The right instrument follows from your stage, your check sizes, and your investors. If you are raising a small early round from angels and pre-seed funds and want to move quickly and cheaply, a SAFE is usually the cleanest choice — provided you carefully track your cumulative dilution and set a cap you can live with. If an investor you want insists on a note, a convertible note is workable, but negotiate a comfortable maturity date and a modest interest rate, and have a credible plan to raise your priced round well before maturity.

If you are raising a larger round with a committed lead who is prepared to set a valuation, a priced round gives you and everyone else certainty and a clean cap table, and is generally the right structure at seed proper and beyond. Whichever you choose, model the fully diluted outcome before you sign — including every cap, discount, and stacked instrument — so you know exactly how much of the company you are committing. And get a lawyer familiar with regional deal structures to review the documents, since the details of conversion mechanics are where founders most often get caught out.

Frequently Asked Questions

What is the main difference between a SAFE and a convertible note? A SAFE is not debt — it has no interest and no maturity date, and simply converts into equity at your next priced round. A convertible note is debt — it accrues interest and has a maturity date by which it must convert or be repaid, which gives the investor leverage if you have not raised in time.

Which instrument is most common at pre-seed? SAFEs have become the dominant instrument at pre-seed, making up the large majority of the earliest-stage deals in recent market data, thanks to their speed and low cost. Convertible notes are still used, often depending on investor preference.

What do valuation caps and discounts actually do? They reward early investors for taking early risk. A cap sets the maximum valuation at which the instrument converts, and a discount gives the investor a reduced price versus the priced round. Both hand early investors more shares — and therefore dilute founders more — than the cash alone would suggest.

When should I do a priced round instead of a SAFE or note? When the round is large enough and you have a lead investor willing to set a valuation — typically at seed proper and certainly by Series A. Priced rounds cost more in legal work but give everyone certainty and avoid deferred dilution surprises.

Can stacking multiple SAFEs hurt me? Yes. Each SAFE promises future equity, and several stacked together — especially with low caps — can convert into far more dilution than founders expect when they all trigger at the priced round. Always model the fully diluted cap table before signing another instrument.

Pick the Right Structure Before You Raise

The instrument you choose shapes your cap table for years. Before you sign a SAFE, a note, or a priced round, get an objective read on your stage, your traction, and the terms you can defend. Run a free Readiness Scan to prepare before you raise.

SAFEs, Convertible Notes & Priced Rounds in the GCC